- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Financially Fit Penny Stocks
New Zealand Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
2
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
2 companies
BLIS Technologies
Market Cap: NZ$17.9m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.014
7D
0%
1Y
-6.7%
Pacific Edge
Market Cap: NZ$101.5m
A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.
PEB
NZ$0.13
7D
1.6%
1Y
45.3%
Page 1 of 1